Stryker annual shareholders’ equity
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Stryker Shareholders’ Equity Growth & History (SYK)
Stryker's shareholders’ equity was $22.42B for fiscal 2025.
View full Stryker company overviewStryker annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $22.42B | $1.79B | +8.66% |
| 2024 | 2024-12-31 | $20.63B | $2.04B | +10.98% |
| 2023 | 2023-12-31 | $18.59B | $1.98B | +11.90% |
| 2022 | 2022-12-31 | $16.62B | $1.74B | +11.69% |
| 2021 | 2021-12-31 | $14.88B | $1.79B | +13.70% |
| 2020 | 2020-12-31 | $13.08B | $277.0M | +2.16% |
| 2019 | 2019-12-31 | $12.81B | $1.08B | +9.18% |
| 2018 | 2018-12-31 | $11.73B | $1.76B | +17.70% |
| 2017 | 2017-12-31 | $9.97B | $416.0M | +4.36% |
| 2016 | 2016-12-31 | $9.55B | $1.04B | +12.21% |
| 2015 | 2015-12-31 | $8.51B | −$84.0M | −0.98% |
| 2014 | 2014-12-31 | $8.60B | −$452.0M | −5.00% |
| 2013 | 2013-12-31 | $9.05B | $450.0M | +5.23% |
| 2012 | 2012-12-31 | $8.60B | $914.0M | +11.90% |
| 2011 | 2011-12-31 | $7.68B | $509.0M | +7.10% |
| 2010 | 2010-12-31 | $7.17B | $578.0M | +8.76% |
| 2009 | 2009-12-31 | $6.60B | $1.19B | +21.97% |
| 2008 | 2008-12-31 | $5.41B | $29.5M | +0.55% |
| 2007 | 2007-12-31 | $5.38B | — | — |
Stryker quarterly shareholders’ equity
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $23.99B | $2.80B | +13.20% |
| Q1 2026 | 2026-03-31 | $22.98B | $2.05B | +9.79% |
| Q4 2025 | 2025-12-31 | $22.42B | $1.79B | +8.66% |
| Q3 2025 | 2025-09-30 | $21.79B | $1.64B | +8.12% |
| Q2 2025 | 2025-06-30 | $21.19B | $1.43B | +7.23% |
| Q1 2025 | 2025-03-31 | $20.93B | $1.76B | +9.17% |
| Q4 2024 | 2024-12-31 | $20.63B | $2.04B | +10.98% |
| Q3 2024 | 2024-09-30 | $20.15B | $2.24B | +12.53% |
| Q2 2024 | 2024-06-30 | $19.76B | $2.40B | +13.83% |
| Q1 2024 | 2024-03-31 | $19.17B | $2.28B | +13.48% |
| Q4 2023 | 2023-12-31 | $18.59B | $1.98B | +11.90% |
| Q3 2023 | 2023-09-30 | $17.91B | $1.44B | +8.76% |
| Q2 2023 | 2023-06-30 | $17.36B | $1.69B | +10.76% |
| Q1 2023 | 2023-03-31 | $16.89B | $1.85B | +12.29% |
| Q4 2022 | 2022-12-31 | $16.62B | $1.74B | +11.69% |
| Q3 2022 | 2022-09-30 | $16.46B | $2.29B | +16.12% |
| Q2 2022 | 2022-06-30 | $15.67B | $1.85B | +13.42% |
| Q1 2022 | 2022-03-31 | $15.05B | $1.54B | +11.44% |
| Q4 2021 | 2021-12-31 | $14.88B | $1.79B | +13.70% |
| Q3 2021 | 2021-09-30 | $14.18B | $1.19B | +9.18% |
| Q2 2021 | 2021-06-30 | $13.82B | $1.07B | +8.36% |
| Q1 2021 | 2021-03-31 | $13.50B | $387.0M | +2.95% |
| Q4 2020 | 2020-12-31 | $13.08B | $277.0M | +2.16% |
| Q3 2020 | 2020-09-30 | $12.99B | $671.0M | +5.45% |
| Q2 2020 | 2020-06-30 | $12.75B | $811.0M | +6.79% |
| Q1 2020 | 2020-03-31 | $13.12B | $1.42B | +12.16% |
| Q4 2019 | 2019-12-31 | $12.81B | $1.08B | +9.18% |
| Q3 2019 | 2019-09-30 | $12.31B | $2.46B | +24.90% |
| Q2 2019 | 2019-06-30 | $11.94B | $2.48B | +26.25% |
| Q1 2019 | 2019-03-31 | $11.69B | $2.48B | +26.90% |
| Q4 2018 | 2018-12-31 | $11.73B | $1.76B | +17.70% |
| Q3 2018 | 2018-09-30 | $9.86B | −$565.0M | −5.42% |
| Q2 2018 | 2018-06-30 | $9.46B | −$575.0M | −5.73% |
| Q1 2018 | 2018-03-31 | $9.21B | −$490.0M | −5.05% |
| Q4 2017 | 2017-12-31 | $9.97B | $416.0M | +4.36% |
| Q3 2017 | 2017-09-30 | $10.43B | $1.09B | +11.71% |
| Q2 2017 | 2017-06-30 | $10.04B | $937.0M | +10.30% |
| Q1 2017 | 2017-03-31 | $9.70B | $896.0M | +10.17% |
| Q4 2016 | 2016-12-31 | $9.55B | $1.04B | +12.21% |
| Q3 2016 | 2016-09-30 | $9.33B | $848.0M | +10.00% |
| Q2 2016 | 2016-06-30 | $9.10B | $593.0M | +6.97% |
| Q1 2016 | 2016-03-31 | $8.81B | $487.0M | +5.85% |
| Q4 2015 | 2015-12-31 | $8.51B | −$84.0M | −0.98% |
| Q3 2015 | 2015-09-30 | $8.48B | −$140.0M | −1.62% |
| Q2 2015 | 2015-06-30 | $8.51B | −$497.0M | −5.52% |
| Q1 2015 | 2015-03-31 | $8.32B | — | — |
| Q4 2014 | 2014-12-31 | $8.60B | −$452.0M | −5.00% |
| Q3 2014 | 2014-09-30 | $8.62B | −$113.0M | −1.29% |
| Q2 2014 | 2014-06-30 | $9.00B | $399.0M | +4.64% |
| Q4 2013 | 2013-12-31 | $9.05B | $450.0M | +5.23% |
| Q3 2013 | 2013-09-30 | $8.74B | $376.0M | +4.50% |
| Q2 2013 | 2013-06-30 | $8.60B | $651.0M | +8.19% |
| Q1 2013 | 2013-03-31 | $8.46B | $434.0M | +5.41% |
| Q4 2012 | 2012-12-31 | $8.60B | $914.0M | +11.90% |
| Q3 2012 | 2012-09-30 | $8.36B | $804.0M | +10.64% |
| Q2 2012 | 2012-06-30 | $7.95B | $174.0M | +2.24% |
| Q1 2012 | 2012-03-31 | $8.02B | $569.6M | +7.64% |
| Q4 2011 | 2011-12-31 | $7.68B | $509.0M | +7.10% |
| Q3 2011 | 2011-09-30 | $7.56B | $251.0M | +3.44% |
| Q2 2011 | 2011-06-30 | $7.78B | $1.03B | +15.31% |
| Q1 2011 | 2011-03-31 | $7.45B | $781.6M | +11.72% |
| Q4 2010 | 2010-12-31 | $7.17B | $578.0M | +8.76% |
| Q3 2010 | 2010-09-30 | $7.31B | $865.1M | +13.43% |
| Q2 2010 | 2010-06-30 | $6.75B | $688.0M | +11.36% |
| Q1 2010 | 2010-03-31 | $6.67B | — | — |
| Q4 2009 | 2009-12-31 | $6.60B | $1.19B | +22.00% |
| Q3 2009 | 2009-09-30 | $6.44B | — | — |
| Q2 2009 | 2009-06-30 | $6.06B | — | — |
| Q4 2008 | 2008-12-31 | $5.41B | — | — |
Stryker shareholders’ equity trends
Over the last five fiscal years, Stryker's shareholders’ equity increased from $13.08B to $22.42B, a change of $9.34B. The latest reported quarter, Q2 2026, shows $23.99B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stryker source filings ↗Community posts
Stryker completes ZuriMED acquisition to broaden its shoulder-repair offering
Stryker ($SYK) completed its acquisition of privately held ZuriMED, adding FiberLocker technology to its sports medicine business. The commercialized product is used to augment rotator cuff repair and is designed to increase the mechanical ...
